DIABETIC RETINOPATHY - PowerPoint PPT Presentation

1 / 54
About This Presentation
Title:

DIABETIC RETINOPATHY

Description:

Venous beading or IRMA (intraretinal microvascular abnormalities) ... Moderate IRMA in at least 1 quadrant. Known as the 4-2-1 rule. Very severe NPDR ... – PowerPoint PPT presentation

Number of Views:3397
Avg rating:3.0/5.0
Slides: 55
Provided by: cmcendo
Category:

less

Transcript and Presenter's Notes

Title: DIABETIC RETINOPATHY


1
DIABETIC RETINOPATHY
  • Some pictures have been taken through Google
    Images.

2
DIABETIC RETINOPATHY
  • Epidemiology and risk factors
  • 2. Classification and features of Diabetic
  • retinopathy (DR)
  • 3. Complications of DR and their prevention
  • 4. Screening protocol for DR and referral to
    Ophthalmologist
  • 5. Direct ophthalmoscopy and identification of
    fundus findings  

3
Epidemiology of DR
  • RISK of developing DR
  • Type I or IDDM 70
  • Type II or NIDDM - 39
  • Type II on insulin 70

4
  • Prevalence of the type of Diabetes
  • Type 2 in 90 of diabetic patients
  • Hence Type 2 in most of the Diabetic
    Retinopathy patients as well
  • Diabetic retinopathy - most common cause of legal
    blindness between ages 20 and 70 years.

5
RISK FACTORS
  • Duration of diabetes
  • Poor control of Diabetes
  • Pregnancy
  • Hypertension
  • Nephropathy
  • Obesity and hyperlipidemia
  • Smoking

6
Pathogenesis
  • Microangiopathy which has features of both
    microvascular leakage and occlusion
  • Larger vessels may also be involved

7
Microvascular leakage
  • Loss of pericytes results in distention of weak
    capillary wall producing microaneurysms which
    leak
  • Blood-retinal barrier breaks down causing plasma
    constituents to leak into the retina retinal
    oedema, hard exudates

8
Microvascular occlusion
  • Basement membrane thickening, endothelial cell
    damage, deformed RBCs, platelet stickiness and
    aggregation
  • Vascular Endothelial Growth Factor (VEGF) is
    produced by hypoxic retina
  • VEGF stimulates the growth of shunt and new
    vessels

9
Classification of DR
  • I. Non-proliferative DR (NPDR)
  • Mild
  • Moderate
  • Severe
  • Very severe
  • Proliferative DR (PDR)
  • III. Clinically significant macular oedema (CSME)
  • - May exist by itself or along with NPDR
    and PDR

10

Mild NPDR
  • At least one microaneurysm - earliest clinically
    detectable lesion
  • Retinal hemorrhages
  • Hard or soft exudates

11
Moderate NPDR
  • Microaneurysms and/or dot and blot hemorrhages in
    at least 1 quadrant
  • Soft exudates (Cotton wool spots)
  • Venous beading or IRMA (intraretinal
    microvascular abnormalities)

12
Mild and Moderate Non- proliferative DR was
previously known as Background DR
13
Severe NPDR
  • Any one of the following 3 features is present
  • Microaneurysms and intraretinal hemorrhages in
    all 4 quadrants
  • Venous beading in 2 or more quadrants
  • Moderate IRMA in at least 1 quadrant
  • Known as the 4-2-1 rule

14
Very severe NPDR
  • Any two of the features of the 4-2-1 rule is
    present

15
Severe and Very severe Non-proliferative DR was
known as the Pre-proliferative DR
16
Clinically significant Macular Oedema
  • Retinal oedema close to fovea
  • Hard exudates close to fovea
  • Presents with dimness of vision
  • By itself or along with NPDR or PDR

17
CSME Hard exudates close to fovea and
associated retinal thickening
18
Proliferative DR (PDR)
  • Characterized by Proliferation of new vessels
    from retinal veins
  • New vessels on the optic disc
  • New vessels elsewhere on the retina

19
Proliferative DR
NVD
20
COMPLICATIONS OF DIABETIC RETINOPATHY
  • Vitreous hemorrhage
  • Tractional retinal detachment
  • Rubeosis Iridis
  • Glaucoma
  • Blindness

21
Vitreous Hemorrhage
SUBHYALOID HEMORRHAGE
22
Tractional retinal detachment
23
Rubeosis Iridis
24
Neovascular Glaucoma
  • Complication of rubeosis iridis
  • New vessels cause angle closure
  • Mechanical obstruction to aqueous outflow
  • Intra ocular pressure rises
  • Pupil gets distorted as iris gets pulled
  • Eye becomes painful and red
  • Loss of vision

25
Blindness
  • Non-clearing vitreous hemorrhage
  • Neovascular glaucoma
  • Tractional retinal detachment
  • Macular ischemia

26
PREVENTION OF COMPLICATIONS
  • By early institution of appropriate treatment
  • This requires early detection of DR in its
  • asymptomatic treatable condition
  • By routine fundus examination of all Diabetics
    (cost effective screening)
  • And appropriate referral to ophthalmologist

27
Mild and Moderate NPDR
  • - No specific treatment for retinopathy
  • Good metabolic control to delay progression
  • Control of associated Hypertension, Anemia and
    Renal failure
  • Severe and very severe NPDR
  • Close follow up by Ophthalmologist

28
Clinically significant macular oedema
  • Laser photocoagulation to minimise risk of visual
    loss
  • Proliferative DR
  • Retinal laser photocoagulation as per the
    judgment of ophthalmologist (in high risk eyes)
  • It converts hypoxic retina (which produces
    ANGIOGENIC factors) into anoxic retina (which
    cant)

29
Screening protocol for Diabetic retinopathy
  • Screening once in a 1 year
  • Diabetics with normal fundus
  • Mild NPDR
  • Screening once in 6 months
  • Moderate NPDR

30
Referral to Ophthalmologist
  • Visual Symptoms
  • Diminished visual acuity
  • Seeing floaters
  • Painful eye
  • Fundus findings
  • - Macular oedema/hard exudates close to fovea
  • - Proliferative DR
  • - Vitreous hemorrhage
  • - Moderate to severe and very severe NPDR
  • Retinal detachment
  • Cataract obscuring fundus view

31
Referral to Ophthalmologist
  • Presence of Risk Factors
  • - Pregnancy
  • - Nephropathy

32
Simulation of defective vision as experienced by
a Diabetic whose vision has been affected by
Diabetic retinopathy
Normal
Defective
33
DIRECT OPHTHALMOSCOPY
  • Examination of the fundus of the eye
  • To screen for Diabetic Retinopathy
  • After dilatation of both eyes with 0.5
    tropicamide
  • Flashlight test, prior to dilatation to detect
    eyes with shallow AC
  • Procedure will be demonstrated

34
Aim the ophthalmoscope light at the pupil at an
angle 15-200 lateral to the visual axis, along
the white line shown in the figure, 10-12 inches
in front of the patients eye. A red reflex
should fill the pupil. Keeping red reflex in
view move closer to about 1 inch in front of
patient when the retina (optic disc) comes into
focus. From this position slightly tilt the
ophthalmoscope to examine other areas around the
optic disc, to trace the blood vessels and view
the macula.
35
The optic disc is seen first as the fundus is
observed along an axis 15-20o lateral to the
visual axis. The macula is viewed by moving the
ophthalmoscope nasally into the visual axis of
the subject, so that the beam of light sweeps the
retina temporal to the disc to fall on the
macula, which is placed lateral to disc.
Left Eye
36
View of the retina through an ophthalmoscope
37
Normal fundus views of Right and left eye
38
NPDR
39
Mild NPDR Microaneurysms, Dot and Blot
hemorrhages
40
(No Transcript)
41
Moderate NPDR
42
Moderate NPDR with CSME
43
Circinate retinopathy Hard exudates in a ring
around leaking aneurysms
44
Age related Macular degeneration Note the
drusen. Not to be confused with Hard exudates.
There are no microaneurysms or dot/blot
hemorrhages.
DRUSEN
45
  • Moderate Severe NPDR
  • Cotton wool patches
  • Hemorrhages - 4 quadrants

With CSME
46
Severe NPDR
Very severe NPDR
  • Venous beading, - scars of laser spots,
  • Absorbing hemorrhages

Cotton-wool patches, venous segmentation
47
CSME in Different Stages of NPDR
48
Proliferative DR New vessels elsewhere on the
retina along the supero-temporal vessels
49
PDR New vessels on disc
50
PDR New vessels on disc and New vessels
elsewhere on retina
51
PDR with vitreous hemorrhage
Vitreous bleed
52
Vitreous Hemorrhage
53
Tractional retinal detachment
Fibro-vascular proliferation
54
Thank you!
Any doubts?
Write a Comment
User Comments (0)
About PowerShow.com